Deontics Clinical Futures

Deontics to support US ambition for high-value care at HIMSS 2015

Deontics to support US ambition for high-value care at HIMSS 2015

Deontics to support US ambition for high-value care at HIMSS 2015

Clinically-led healthcare artificial intelligence provider Deontics is looking to build on its US activity by attending HIMSS 2015, the world’s health technology conference being held in Chicago in 12-16 April 2015.

The firm provides physicians with a state-of-the-art clinical ‘sat nav’ for personalized care, and will seek to build on its relationships with US and UK clinical providers, electronic records companies and clinical guideline writing organizations to show how it can put actionable intelligence directly into clinical workflow.

Deontics’ products support all the key principles of the Office of the National Coordinator for Health Information Technology’s Federal Health IT Strategic Plan 2015- 2020 which aims to deliver high-value health care through, in part, the creation of evidence-based tools.

Dr Guy Wood-Gush, CEO of Deontics said: “Having already worked with organizations such as a top five US pharmaceutical company, the American Association of Consultant Endocrinologists (AACE), and a top five US hospital group, we’re keen to discuss the benefits of personalized care and our experience in this field, at HIMSS 2015.

“Our technology links scientific research and evidence into everyday clinical practice, helping providers to continuously learn, improve performance and deliver more effective and efficient patient care.”

Deontics provides robust, transparent and auditable clinical performance and resource data that can support clinical performance measurement, research, medical legal investigations and pre-authorization of treatment at an individual and population level.

Its advanced clinical pathways and decision support functionality is helping to improve patient outcomes in the US and UK. Its interoperable architecture means it can help electronic health record providers realize the potential of clinical decision support quickly and effectively.

Healthcare variation and negligence claims can be minimized through relevant use of personalized, clinical guidelines and protocols. The technology is being used to tackle major health challenges such as cancer and diabetes across the globe, and has the potential to transform clinical practice.

Deontics’ technologies are the results of long-term academic research in medical artificial intelligence originating at Carnegie Mellon University, and subsequently developed at the Medical Research Council, University of Oxford, University College London and Cancer Research UK.

To arrange a discussion or meeting on the opportunities that Deontics provides, contact Guy Wood-Gush on +44 (0)7725 333835 or guy.wood-gush@deontics.com For more information visit the Deontics website.

Also available at the event, will be Deontics’ chief technology officer Dr Ioannis Chronakis (ioannis.chronakis@deontics.com; +44 7813 131443), and chief medical officer Mr Vivek Patkar (vivek.patkar@deontics.com; +44 7947329072).

Notes to editors

About Deontics:

Deontics is an Artificial Intelligence (AI) company with world-leading clinical pathway and clinical decision support technologies. Deontics’ technologies are the results of long-term academic research in medical AI originating at Carnegie Mellon University, and subsequently developed at the MRC, CRUK, Oxford and UCL. Deontics technologies were developed from first principles for clinical use incorporating concepts from cognitive psychology and computer science. Deontics can utilize descriptive and predictive analytic outputs to create prescriptive analytics solutions.

Deontics pathway and decision products render relevant, personalized evidence items from clinical guidelines and protocols at a highly granular level at the point of care and have been shown to increase compliance with clinical guidelines in practice. These products have the potential to substantially increase clinical performance standardization and patient safety both at unit level and across sites or regions effectively combating the ‘postcode lottery’. Because decision data are captured alongside outcomes and other clinical data, Deontics provides, the capability to fully ‘measure’ clinical practice and provide a benchmark for improvement.

For more information visit www.deontics.com

Deontics UK eHealth Week news alert

Deontics to promote evidence-based care at UK eHealth Week 2015

Deontics to promote evidence-based care at UK eHealth Week 2015

A university and national cancer charity spinout that provides clinically-led artificial intelligence is to showcase its state-of-the-art technology at HC2015, part of the UK eHealth Week 2015. Deontics technology delivers innovative decision-support and executable pathway solutions to improve healthcare outcomes and patient safety.
Deontics was formed to promote and help deliver evidence-based and personalised medicine as a spinout of the University of Oxford, University College London and Cancer Research UK. The firm has already built new pathways for a large US hospital group, a national US clinical guideline organisation, NHS trusts and built a lung cancer system for a top 10 US pharmaceutical company.

The Deontics’ team will be on stand 74, Olympia National Hall, London on 3rd and 4th March, where it will show how non-technical users can work with the company’s technology to design new and improved pathways that bring personalised clinical guidelines and best practice directly into clinical workflow.

Dr Guy Wood-Gush, CEO of Deontics, said: “Technology will play an increasingly vital role in patient safety, as we have seen described in the ambitions of the National Information Board to avoid “unacceptable variations” in treatments and outcomes. This ambition is achievable now – the technology is currently available to make actionable intelligence accessible at the point of care delivery”.

“We invite delegates and fellow exhibitors of UK eHealth Week to see how our clinical decision support platform can help drive out unwarranted variability in clinical practice across the globe.”

Deontics’ technology uses the PROforma computer language to encode clinical and other guidelines into computer readable format. This platform enables a range of applications, such as individualised treatment recommendations, quality alerts, clinical trial eligibility, audit, and care pathway management and clinical workflow.

Its clinical application integrates local, national and international best practice and guidelines with patient-level data, and then presents outputs such as treatment recommendations to clinicians through a web-based user interface.

Deontics provides clinically-led artificial intelligence technology that can support future models of care with the ability to help clinicians and others design, implement and monitor new and existing care pathways without the need to know computer code.

About UK eHealth Week
UK eHealth Week, which is one of the biggest eHealth events in the UK and free for NHS staff to attend, is hosted by two large organisations for eHealth: BCS and HIMSS. The week-long event includes the HC2015 conference which takes place in Olympia’s National Hall in London on the 3rd and 4th March 2015.

The event will bring together many important figures from the healthcare industry, providing a forum for networking and discussions around all aspects of eHealth. It features speakers such as Jeremy Hunt, the Secretary of State for Health; Tim Kelsey national director for patients and information; Beverly Bryant, director of strategic systems & technology; Professor Sir Bruce Keogh national medical director; and Simon Stevens, chief executive of NHS England.

To arrange a demonstration of the solution at the event email Dr Guy Wood-Gush at guy.wood-gush@deontics.com or visit stand 74 on 3rd or 4th March.